Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.54 - $1.41 $121,563 - $317,414
-225,117 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$1.4 - $5.15 $85,636 - $315,020
61,169 Added 37.31%
225,117 $324,000
Q4 2021

Feb 14, 2022

BUY
$4.27 - $6.97 $85,429 - $139,448
20,007 Added 13.9%
163,948 $856,000
Q3 2021

Nov 15, 2021

BUY
$5.31 - $8.25 $27,240 - $42,322
5,130 Added 3.7%
143,941 $839,000
Q2 2021

Aug 16, 2021

BUY
$6.81 - $9.23 $183,529 - $248,748
26,950 Added 24.09%
138,811 $1.12 Million
Q1 2021

May 17, 2021

SELL
$7.99 - $15.0 $215,698 - $404,940
-26,996 Reduced 19.44%
111,861 $931,000
Q4 2020

Feb 16, 2021

BUY
$7.04 - $11.7 $977,553 - $1.62 Million
138,857 New
138,857 $1.05 Million
Q3 2020

Nov 16, 2020

SELL
$9.98 - $18.04 $992,540 - $1.79 Million
-99,453 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$7.49 - $15.16 $268,067 - $542,576
35,790 Added 56.22%
99,453 $1.51 Million
Q1 2020

May 15, 2020

BUY
$4.62 - $18.74 $176,992 - $717,929
38,310 Added 151.11%
63,663 $530,000
Q4 2019

Feb 14, 2020

BUY
$14.6 - $18.13 $370,153 - $459,649
25,353 New
25,353 $428,000
Q3 2019

Nov 14, 2019

SELL
$16.62 - $23.92 $462,019 - $664,952
-27,799 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$17.79 - $22.88 $225,559 - $290,095
-12,679 Reduced 31.32%
27,799 $636,000
Q1 2019

May 15, 2019

BUY
$11.76 - $22.15 $337,312 - $635,328
28,683 Added 243.18%
40,478 $851,000
Q4 2018

Feb 14, 2019

SELL
$10.42 - $21.94 $386,217 - $813,206
-37,065 Reduced 75.86%
11,795 $136,000
Q3 2018

Nov 14, 2018

BUY
$20.4 - $24.6 $85,863 - $103,541
4,209 Added 9.43%
48,860 $1.12 Million
Q2 2018

Aug 14, 2018

SELL
$19.02 - $24.95 $291,633 - $382,558
-15,333 Reduced 25.56%
44,651 $996,000
Q1 2018

May 15, 2018

BUY
$22.55 - $29.9 $643,982 - $853,884
28,558 Added 90.87%
59,984 $1.37 Million
Q4 2017

Feb 14, 2018

SELL
$18.0 - $30.0 $7,470 - $12,450
-415 Reduced 1.3%
31,426 $823,000
Q3 2017

Nov 14, 2017

BUY
$21.1 - $25.15 $671,845 - $800,801
31,841
31,841 $715,000

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $191M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.